23andMe, facing significant operational challenges, is cutting its workforce by 40% amid a board resignation and stock price decline, raising concerns about genetic data security.
CEO Anne Wojcicki's intention to take 23andMe private and refusal to entertain third-party buyout offers showcases the ongoing uncertainty and tumult within the company and its future.
Despite users consenting to data sharing for research, the resale of genetic information during potential ownership transfers could raise serious privacy concerns for customers.
Experts highlight the importance of consumer vigilance as new ownership could result in altered privacy agreements, emphasizing users' need to safeguard their genetic data.
Collection
[
|
...
]